The Advent of CAR T-Cell Therapy for Lymphoproliferative Neoplasms: Integrating Research Into Clinical Practice
Research on CAR T cells has achieved enormous progress in recent years. After the impressive results obtained in relapsed and refractory B-cell acute lymphoblastic leukemia and aggressive B-cell lymphomas, two constructs, tisagenlecleucel and axicabtagene ciloleucel, were approved by FDA. The role o...
Збережено в:
| Автори: | , , , , , , , , , , , , , |
|---|---|
| Формат: | Revisão |
| Мова: | Англійська |
| Опубліковано: |
2020
|
| Онлайн доступ: | https://doi.org/10.3389/fimmu.2020.00888 https://www.frontiersin.org/articles/10.3389/fimmu.2020.00888/pdf |
| Теги: |
Додати тег
Немає тегів, Будьте першим, хто поставить тег для цього запису!
|